The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
作者信息
Oliver M F
出版信息
Bull N Y Acad Med. 1968 Aug;44(8):1021-7.
Abstract
摘要
相似文献
1
The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).用安妥明（氯贝丁酯）对缺血性心脏病进行一级预防。
Bull N Y Acad Med. 1968 Aug;44(8):1021-7.
2
Clofibrate and androsterone effect on serum lipids.
Arch Intern Med. 1967 Jan;119(1):80-5.
3
[Effect of Atromid on blood lipids in patients with hyperlipemia].[安妥明对高脂血症患者血脂的影响]
Ter Arkh. 1968 Mar;40(3):15-20.
4
5
[Action mechanism and clinical success of Regelan (Clofibrate)].[氯贝丁酯的作用机制与临床疗效]
Wien Klin Wochenschr. 1967 Sep 29;79(39):716-20.
6
[The treatment of exudative diabetic retinopathies with clofibrate (Atromid-S)].[用氯贝丁酯（安妥明）治疗渗出性糖尿病视网膜病变]
Ned Tijdschr Geneeskd. 1967 Nov 11;111(45):2039-40.
7
[The effect of Atromid treatment of patients with essential hyperlipidemia and xanthomatosis].[安妥明治疗原发性高脂血症和黄瘤病患者的疗效]
Ter Arkh. 1967 Jul;39(7):61-3.
8
9
[Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].[对氯苯氧异丁酸2-乙酯降血脂作用研究的临床贡献]
Clin Ter. 1969 Jul 15;50(1):11-26.
10
Control of biochemical precursors of coronary heart disease.
Geriatrics. 1969 Dec;24(12):61-6.
引用本文的文献
1
Clofibrate, serum enzymes, and muscle pain.氯贝丁酯、血清酶与肌肉疼痛。
Br Med J. 1970 Apr 11;2(5701):86-8. doi: 10.1136/bmj.2.5701.86.
2
A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress.一项使用氯贝丁酯进行缺血性心脏病一级预防的合作试验：设计、方法与进展。
Bull World Health Organ. 1973;48(2):243-56.
本文引用的文献
1
Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate.氯苯丁酯对脂质代谢及分布的影响
Nature. 1962 Jun 9;194:948-9. doi: 10.1038/194948a0.
Zotero 插件